Benzamide derivatives are known for its versatile medicinal properties.[1] Some of the pharmacological properties of benzamide derivatives include antipsychotic, [2] antihypertensive, [3] antibacterial[4]and antimicrobial [5] properties. The structure of the claimed compounds has been shown in [Figure 1].The synthesis of benzamides have been reported by many authors.[6]
Figure 1 : Compounds SG1 and SG2
Materials and Methods
TLC was performed on 524nm Merk TLC plates. All chemicals were of synthetic grade and 98% purisis grade. TLC was eluted with 3 different solvents to check the purity of the compounds and visualized in Iodine chamber and further in UV chamber. The 1H-NMR was performed on Bruker 400 MHZ NMR before which FT-IR was performed on Perkin Elmer spectrophotometer. The synthetic scheme for the claimed compounds has been shown in [Figure 2].
Synthetic scheme
Figure 2 : Synthetic Scheme for compound SG1 and SG2
N-(2aminoethyl)-2-chlorobenzamide (SG1):An equimolar solution of ethylene diamine was dissolved in 10 ml of ethanolic 1 N NaOH in round bottom flask and to it 2-Chlorobenzoyl chloride was added dropwise from dropping funnel with continuous stirring for 3 hrs at room temperature. The stirring was conducted on magnetic stirrer with magnetic bead in the ethylene diamine solution. The compound that separated out after 3 hrs was dried. The compound SG1 was washed with ethanol and further dried again washed with NaOH and water and air dried.
2-chloro-N-(propan-2-yl) benzamide (SG2): The procedure for the SG1 was repeated and in place of ethylene diamine, isopropyl amine was used. Rest of the procedure remains same.
The compounds complied with IR and NMR spectral data and confirmed to be syhthesized.
Conclusion
From the IR and 1H-NMR data of the compounds, it was confirmed that the compounds were synthesized in Part-I of this paper. Further the evaluation of the compounds shall be done in Part-II of the paper.
Source of Funding
None.
Conflict of Interest
None.
References
K Itoh, H Tomozane, H Hakira, S Sonda, K Asano, M Fujimura. Synthesis and pharmacological properties of novel benzamide derivatives acting as ligands to the 5-hydroxytryptamine 4 (5-HT4) receptor. . Eur J Med Chem 1999. [Google Scholar]
AB Reitz, EW Baxter, EE Codd, CB Davis, AD Jordan, BE Maryanoff. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic α1 receptors. J Med Chem 1998. [Google Scholar]
S Fujii, E Kikuchi, Y Watanabe, H Suzuyama, MI Yuasa, T Mori. Structural development of N-(4-phenoxyphenyl) benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling. Bioorganic Med Chem Lett 2020. [Google Scholar]
NR Stokes, N Baker, JM Bennett, PK Chauhan, I Collins, DT Davies. Design, synthesis and structure–activity relationships of substituted oxazole–benzamide antibacterial inhibitors of FtsZ.. Bioorganic Med Chem Lett 2014. [Google Scholar]
C Acar, G Yalçın, TE Bolelli, FK Onurdağ, S Ökten, F Şener. Synthesis and molecular docking studies of some novel antimicrobial benzamides.. Bioorganic Chem 2020. [Google Scholar]
E Kalinichenko, A Faryna, V Kondrateva, A Vlasova, V Shevchenko, A Melnik. Synthesis, biological activities and docking studies of novel 4-(arylaminomethyl) benzamide derivatives as potential tyrosine kinase inhibitors. Molecules 2019. [Google Scholar]